PHARMACEUTICAL COMPOUNDS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090124610A1
SERIAL NO

12298384

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

is hydrogen or a substituent. The compounds of the formula (I) have PKA and PKB kinase inhibiting activity and are useful in the treatment of cancers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CANCER RESEARCH TECHNOLOGY LIMITEDANGEL BUILDING 407 ST JOHN STREET LONDON EC1V4AD
ASTEX THERAPEUTICS LIMITEDCAMBRIDGE CAMBRIDGESHIRE CB4 0QA
THE INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL123 OLD BROMPTON ROAD LONDON SW7 3RP

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Caldwell, John Sutton , GB 76 1581
Cheung, Kwai-Ming Staines , GB 2 7
Collins, Ian Redhill , GB 93 1712
Da, Fonseca McHardy Tatiana Faria Sunbury-on-thames , GB 4 9
Saxty, Gordon Cambridge , GB 55 1129
Verdonk, Marinus Leendert Burwell , GB 13 119

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation